drug

BEAM-201

Phase 2updated 3mo ago

by $BEAM Beam Therapeutics Inc.

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying BEAM-201

phase1Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphomarecruitingn=33
phase2A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)active not recruitingn=5

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 49m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

BEAM-201

Phase 2updated 3mo ago

by $BEAM Beam Therapeutics Inc.

Phase 2

community read0 votes

all catalysts(0)

nothing on the calendar yet

Trials studying BEAM-201

phase1Anti-CD7 CAR-T Cells in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia or Lymphomarecruitingn=33
phase2A Study Evaluating the Safety and Efficacy of BEAM-201 in Relapsed/Refractory T-Cell Acute Lymphoblastic Leukemia (T-ALL) or T-Cell Lymphoblastic Lymphoma (T-LL)active not recruitingn=5

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 49m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

BEAM-201

all catalysts(0)

Trials studying BEAM-201

News(0)

Report a data issue

comments(0)

BEAM-201

all catalysts(0)

Trials studying BEAM-201

News(0)

Report a data issue

comments(0)